dtrmwxhs-12
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2016 (NCT02900716)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tyrosine-protein kinase BTKINHIBITOR
BTK inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dtrmwxhs-12
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03836768 | Phase 1 | Jan 11, 2019 | Zhejiang DTRM Biopharma |
| NCT02891590 | Phase 1 | Sep 1, 2016 | Zhejiang DTRM Biopharma |
| NCT02900716 | Phase 1 | Sep 1, 2016 | Zhejiang DTRM Biopharma |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zhejiang DTRM Biopharma | For profit | 3 | 3 | 1 | 2016 |
1 organizations
Page 1 / 1